Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > Reverse split is never good

<< Previous

Bullboard Posts

Next >>

Comment by winnerscircleon Jan 11, 2021 5:39pm

150 Views

Post# 32272263

RE:Reverse split is never good

The RS is being done to get on the nasdaq ......much deeper pockets there ....Lexaria has the tech and the right contacts...this will hit 150mill+ MC and IF float stays small we can have bursts of 250mill+MC bursts .....goodbye OTC...hello big daddy Nasdaq!!

<< Previous

Bullboard Posts

Next >>

MDA Space stock blasts off on Q3 financial results